![Close Up Of An Indian Young Woman Getting Taking A Covid Self Test In The Kitchen](https://assets1.cbsnewsstatic.com/hub/i/r/2022/01/03/1839fb87-1633-4a6b-b48d-7e8ff730a222/thumbnail/640x360/ea37f474dfa8beaf9d214a687a3cdaa1/gettyimages-1345296754.jpg?v=8f1da8ceea4c14a7119ef5d6a2829966#)
At-home COVID-19 tests are in stock on this unlikely site
Health company Ro, once known for cheeky ads promising to treat erectile dysfunction and hair loss, has COVID-19 tests in stock.
Watch CBS News
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to discuss her reporting.
Previously, she worked as a breaking news reporter for the New York Daily News. She traveled to Puerto Rico after Hurricane Maria devastated the island and again on the storm's one year anniversary. Her reporting was cited by numerous outlets, including NY1.
As a student at the Craig Newmark Graduate School of Journalism at CUNY, she was awarded the Dennis Duggan prize for her outstanding coverage of ordinary New Yorkers by the Silurians Press Club.
She holds an MA in journalism from CUNY and a BA from Brown University. She is fluent in French, Spanish and Italian.
Health company Ro, once known for cheeky ads promising to treat erectile dysfunction and hair loss, has COVID-19 tests in stock.
A deal with the White House to forego profits has expired, making tests costlier — if they are even in stock.
Individuals are conducting home science experiments in which they film themselves misusing rapid COVID-19 tests.
One expert expects "heroic" discounts on goods in January, but it's hard to predict what items will be on sale.
As Omicron cases soar, America's largest city is rolling out a financial incentive for people to get a booster shot.
Nation's testing bandwidth is no match for Omicron. "We are definitely lagging in our capacity," said one expert.
Restaurants shuttered, sporting events postponed and colleges sent students home early in what feels like a reprise of 2020.
Even CEO opponents of remote work are accepting it's not a good time to return to the office as COVID-19 cases rise.
"This is not quite how we expected to end the semester," officials at one school said as infections surge.
Clinics are charging hundreds of dollars to deliver lab-based molecular test results within hours: "The private jet of testing."
After COVID-19 shut down last year's festivities, in-person company gatherings are making a comeback.
Another virus wave and uncertainty over the Omicron variant is throwing a wrench in companies' office return plans.
Mississippi hospital dismisses physician after he sought to administer anti-parasite drug to three people with COVID-19.
Cities like Tulsa, Oklahoma, are competing for workers who are up for grabs now that they can work from anywhere.
Ford follows in Google's footsteps as the Omicron variant derails companies' plans to bring workers back to offices.